| Previous Section | Index | Home Page |
23 Oct 2008 : Column 522W—continued
Obesity
Mike Penning: To ask the Secretary of State for Health pursuant to the answer of 6 October 2008, Official Report, column 457W on Health: obesity, which public service agreements published by the Government between 1998 and 2004 were related to levels of obesity; and what evidence he has assessed on the effect these targets have had on levels of obesity. [228979]
Dawn Primarolo: I refer the hon. Member to my reply of 6 October 2008, Official Report, column 457W.
The Government commissioned the Foresight team to undertake a detailed analysis on obesity in the United Kingdom. The Foresight report “Tackling Obesities: Future Choices”, which has been placed in the Library, set out the long-term scale of the obesity problem, and its complexities. In response, we have set a new ambition, and developed a new strategy “Healthy Weight”, “Healthy
Lives: a Cross-Government Strategy for England”, which we published in January this year. This has already been placed in the Library.
Obesity: Children
Mike Penning: To ask the Secretary of State for Health for what reasons the Government did not set a target to reduce levels of obesity in children between 1997 and 2004. [228994]
Dawn Primarolo: I refer the hon. Member to the reply I gave on 6 October 2008, Official Report, column 457W.
A public service agreement (PSA) target was set in 2004 to halt the year on year rise in obesity among children aged 11 by 2010 in the context of a broader strategy to tackle obesity in the population as a whole.
Patients: Safety
Dr. Gibson: To ask the Secretary of State for Health what progress is being made towards (a) designation of specialised services to guarantee patient safety and (b) ensuring that service staff are used effectively in accordance with his Department’s operating framework for 2008-09. [228651]
Ann Keen: The process of designating the providers of specialised services is being undertaken as part of the work programme of the National Specialised Commissioning Group, which has issued guidance to Specialised Commissioning Groups (SCGs) on its expected approach. This includes model documentation—to ensure that the process is fair and transparent. Such documentation will need to cover details of the service model, service standards, patient access and egress criteria and treatment protocols, and information requirements. It will also need to be discussed with patient groups. The work of producing model documentation for the first 15 services has been divided between different SCGs. A further eight services will be designated following some form of nationally co-ordinated review (e.g. burn care or rare cancers).
Prostate Cancer
Mark Hunter: To ask the Secretary of State for Health (1) what steps his Department has taken to ensure that cancer networks adhere to the National Institute for Health and Clinical Excellence guidance on prostate cancer; [229316]
(2) has taken to ensure that prostate cancer patients are reviewed by multi-disciplinary teams in all primary care trusts. [229320]
Ann Keen: Improving Outcomes in Urological Cancer, published by the National Institute for Health and Clinical Excellence in 2002, addresses the care of prostate cancer patients.
Strategic health authorities have submitted action plans to demonstrate how they will implement this guidance. The Department and the Healthcare Commission monitor progress against these plans.
The most recent round of peer review visits confirmed that the care of most cancer patients is managed by multidisciplinary teams, one of the key principles of the Improving Outcomes series of guidance.
Mark Hunter: To ask the Secretary of State for Health how much funding is available for treatment of metastatic prostate cancer in (a) England, (b) each strategic health authority area and (c) each primary care trust in 2008-09. [229317]
Ann Keen: It is the responsibility of each primary care trust (PCT) to commission healthcare services for their local populations, including the treatment of metastatic prostate cancer, using the funds allocated to them in their baseline allocations.
A table showing the revenue allocations made to each PCT in 2008-09 has already been placed in the Library.
The following table shows the total revenue allocation provided to each strategic health authority (SHA) area in 2008-09 and the overall total for England.
| SHA | 2008-09 recurrent allocation (£000) |
Mark Hunter: To ask the Secretary of State for Health how many clinical nurse specialists for prostate cancer there were in (a) England, (b) each strategic health authority area and (c) each primary care trust area in each year since 1997. [229319]
Ann Keen: The information requested is unavailable. Work force planning is a matter for local determination. It is for local service providers and work force planners to determine the needs of their local populations for clinical nurses specialists for prostate cancer.
Thame Community Hospital: Finance
John Howell: To ask the Secretary of State for Health when he expects to (a) announce the amount of funding Thame Community Hospital, Oxfordshire, will receive from the Community Hospital Development Fund and (b) make public information on the draw-down terms associated with such funding. [229332]
Mr. Bradshaw: The Department has authorised a contribution from the community hospitals and services programme central fund of £4 million for the redevelopment of Thame Community Hospital and the local NHS is progressing the scheme. The draw down of funding is subject to the normal business case processes.
The new hospital will offer local people better access to wide range of local services and diagnostics, in high quality, up to date, facilities.
Tuberculosis: Vaccination
Mike Penning: To ask the Secretary of State for Health which countries are classified as possessing a level of tuberculosis infection sufficient to justify the treatment of their nationals as a high risk group under the new guidelines for the national BCG vaccination programme. [228988]
Dawn Primarolo: The Bacillus Calmette-Guerin (BCG) vaccination programme offers the BCG vaccine to those at greatest risk of exposure. These are:
all infants (aged 0 to 12 months) living in areas of the UK where the annual incidence of tuberculosis (TB) is 40 in 100,000 or greater;
all infants (aged 0 to 12 months) with a parent or grandparent who was born in a country where the annual incidence of TB is 40 in 100,000 or greater;
previously unvaccinated children aged one to five years with a parent or grandparent who was born in a country where the annual incidence of TB is 40 in 100,000 or greater. These children should be identified at suitable opportunities, and can normally be vaccinated without tuberculin testing;
previously unvaccinated, tuberculin-negative children aged from six to under 16 years of age with a parent or grandparent who was born in a country where the annual incidence of TB is 40 in 100,000 or greater. These children should be identified at suitable opportunities, tuberculin tested and vaccinated if negative;
previously unvaccinated tuberculin-negative contacts of cases of respiratory TB; and
previously unvaccinated, tuberculin-negative new entrants under 16 years of age who were born in or who have lived for a prolonged period (at least three months) in a country with an annual TB incidence of 40 in 100,000 or greater.
BCG may be required for previously unvaccinated, tuberculin negative individuals according to the destination and nature of travel. BCG vaccine is recommended for those under 16 years of age who are going to live or work with local people for more than three months in a country where the annual incidence of TB is 40 in 100,000 or greater.
The following countries have an annual incidence of TB equal to or greater than 40 in 100,000 people.
Afghanistan
Algeria
Angola
Armenia
Azerbaijan
Bahrain
Bangladesh
Belarus
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Cape Verde
Central African Republic
Chad
China
China, Hong Kong SAR
China, Macao SAR
Colombia
Comoros
Congo
Cote d'Ivoire
Croatia
Djibouti
Dominican Republic
DPR Korea
DR Congo
Ecuador
El Salvador
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Georgia
Ghana
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
India
Indonesia
Iraq
Kazakhstan
Kenya
Kiribati
Kyrgyzstan
Lao PDR
Latvia
Lesotho
Liberia
Lithuania
Madagascar
Malawi
Malaysia
Maldives
Mali
Marshall Islands
Mauritania
Micronesia
Mongolia
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Nicaragua
Niger
Nigeria
Niue
Northern Mariana Islands
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Qatar
Rep. of Korea
| Next Section | Index | Home Page |